to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The Millennium Challenge Corporation (MCC) is a United States Government corporation designed to work with some of the poorest countries in the world.
Small biotechnology firms represent a unique national resource for economic growth that may be the fastest and most efficient mechanism to create technological innovation to convert cutting edge biomedical research into new technology breakthroughs and competitive new products. The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer(STTR) grant programs provide an opportunity for ALL key players in biomedical research to benefit. SBIR grants provide $850,000 (Phase I and II) or more and STTR grants provide $600,000 (Phase I and II) or more in research dollars to catalyze the commercialization of innovative projects that will benefit public health. Further, these grants offer company scientists an opportunity to pursue innovative projects for which company support may not be available, and they promote and foster partnerships with collaborators, including academic investigators. By serving as a collaborator, consultant, or principal investigator (for STTR), an academic investigator can gain long-term financial and scientific benefits. Collaboration with a company also offers access to company resources and expertise and possibly jobs for graduate students and postdoctoral fellows. In a rapidly changing culture where research institutions are becoming more committed to innovation and entrepreneurship to enhance the economic development of their regions, NIH SBIR and STTR grants can add value to an academic institution’s intellectual property. With rapidly expanding biological knowledge, even large corporations can develop only a limited number of promising lead ideas. Large pharmaceutical corporations often look to small biotechnology companies for the initial development of embryonic technology. Thus, the end of a successful project for a small biotechnology company is often the beginning of R&D for a large pharmaceutical corporation. NIH small business grants can help bridge the needs of both by providing early-stage funding for research that adds value to an idea, promoting partnerships that lead to a marketable product.
NIH Lab to Life Funding Guide
While confusing to investors, mixing financial investments with philanthropic giving is a concept that is gaining ground. Good Capital is one organization collecting a portfolio of social enterprises and provides funding for their "social good" along with cash returns to their investors.
An angel investor provides a succinct set of tips on how to pitch your company to investors. Key advice: project confidence and boil your pitch down to one or two sentences to establish a frawework for the audience.
All businesses, no matter what type or size, need to properly develop a plan for their expected cash intake and spending. This tool discusses the purposes of cash budgeting, developing budgets, checking the reasonableness of the budget, and specific aspects of the common cash budget.
This tool will step you through the process of preparing and understanding your balance sheet and the many uses for it.
Bringing new board members into your company can be complicated. Brad Feld provides some best practices for managing this complex process, including: recruiting, analyzing current board composition, and establishing selection criteria.
This article offers several ways entrepreneurs can bootstrap their companies along. Tips include start your business at home, evaluate your business equipment needs before buying, and learn to barter.
There are pros and cons associated with using a convertible note structure before doing a Series A round of investment. A venture capitalist explains the ins and outs with a brief, straightforward introduction, including blog comments from other sources.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.